Gammalinolenic acid and dihomogammalinolenic acid suppress the CD3- mediated signal transduction pathway in human T cells

Clinical Immunology and Immunopathology

Volumn 83, Issue 3, 1997, Pages 237-244

  Vassilopoulos, Dimitrios ^a   Zurier, Robert B ^b   Rossetti, Ronald G ^b   Tsokos, George C ^a  

^a WALTER REED ARMY INSTITUTE OF RESEARCH   (United States)

^b UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADENOSINE TRIPHOSPHATASE (CALCIUM); CALCIUM; CD3 ANTIGEN; DIHOMO GAMMA LINOLENIC ACID; GAMMA LINOLENIC ACID; THAPSIGARGIN;

ANTIGEN EXPRESSION; ARTICLE; CALCIUM METABOLISM; CONTROLLED STUDY; DRUG MECHANISM; ENDOPLASMIC RETICULUM; FATTY ACID METABOLISM; HUMAN; HUMAN CELL; IMMUNOSUPPRESSIVE TREATMENT; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SIGNAL TRANSDUCTION; T LYMPHOCYTE ACTIVATION;

EID: 0031172667     PISSN: 00901229     EISSN: None     Source Type: Journal    
DOI: 10.1006/clin.1997.4343     Document Type: Article

References (29)

1. Callegari P. E., Zurier R. B. Botanical lipids: Potential role in modulation of immunologic responses and inflammatory reactions. Rheum. Dis. Clin. North Am. 17:1991;415-425.
2. Zurier B. Essential fatty acids and inflammation. Ann. Rheum. Dis. 50:1991;745-746.
3. Kunkel S. L., Ogawa H., Conran P. B., Ward P. A., Zurier R. B. Suppression of acute and chronic inflammation by orally administered prostaglandins. Arthritis Rheum. 24:1981;1151-1158.
4. Tate G., Mandell B. F., Laposata M., Ohliger D., Baker D. G., Schumacher H. R., Zurier R. B. Suppression of acute and chronic inflammation by dietary gamma linolenic acid. J. Rheumatol. 16:1989;729-734.
5. Leventhal L. J., Boyce E. G., Zurier R. B. Treatment of rheumatoid arthritis with gammalinolenic acid. Ann. Intern. Med. 119:1993;867-873.
6. Zurier R. B., Rossetti R. G., Jacobson E. W., DeMarco D. M., Liu N. Y., Temming J. E., White B. M., Laposata M. gamma-linolenic acid treatment of rheumatoid arthritis. A randomized, placebo-controlled trial. Arthritis Rheum. 39:1996;1808-1817.
7. Zurier R. B. Role of prostaglandins E in inflammation and immune responses. Adv. Prostaglandin. Thromboxane. Leukot. Res. 21B:1991;947-953.
8. Santoli D., Zurier R. B. Prostaglandin E precursor fatty acids inhibit human IL-2 production by a prostaglandin E-independent mechanism. J. Immunol. 143:1989;1303-1309.
9. Santoli D., Phillips P. D., Colt T. L., Zurier R. B. Suppression of interleukin 2-dependent human T cell growth in vitro by prostaglandin E (PGE) and their precursor fatty acids. Evidence for a PGE-independent mechanism of inhibition by the fatty acids. J. Clin. Invest. 85:1990;424-432.
10. A. Weiss, 1993, T lymphocyte activation, Fundamental Immunology, 467, 504, Raven Press, New York.
11. Ullman K. S., Northrop J. P., Verweij C. L., Crabtree G. R. Transmission of signals from the T lymphocyte antigen receptor to the genes responsible for cell proliferation and immune function: The missing link. Annu. Rev. Immunol. 8:1990;421-452.
12. Imboden J. B., Stobo J. D. Transmembrane signalling by the T cell antigen receptor. Perturbation of the T3-antigen receptor complex generates inositol phosphates and releases calcium ions from intracellular stores. J. Exp. Med. 161:1985;446-456.
13. Berridge M. J. Inositol trisphosphate and calcium signalling. Nature. 361:1993;315-325.
14. Gardner P. Calcium and T lymphocyte activation. Cell. 59:1989;15-20.
15. Rabinovitch P. S., June C. H., Grossmann A., Ledbetter J. A. Heterogeneity among T cells in intracellular free calcium responses after mitogen stimulation with PHA or anti-CD3. Simultaneous use of indo-1 and immunofluorescence with flow cytometry. J. Immunol. 137:1986;952-961.
16. 2+2+2+. Eur. J. Immunol. 20:1990;2269-2275.
17. 2+. Proc. Natl. Acad. Sci. USA. 87:1990;2466-2470.
18. Brenner R. R. Effect of unsaturated acids on membrane structure and enzyme kinetics. Prog. Lipid Res. 23:1984;69-96.
19. Clandinin M. T., Cheema S., Field C. J., Garg M. L., Venkatraman J., Clandinin T. R. Dietary fat: Exogenous determination of membrane structure and cell function. FASEB J. 5:1991;2761-2769.
20. McMurchie E. J. Dietary lipids and the regulation of membrane fluidity and function. Aloia R. C. Physiological Regulation of Membrane Fluidity. 1988;189-237 A. R. Liss, New York.
21. 2+. Cell Calcium. 12:1991;449-455.
22. 2+. Biochim. Biophys. Acta. 1092:1991;358-366.
23. Breittmayer J. P., Pelassy C., Cousin J. L., Bernard A., Aussel C. The inhibition by fatty acids of receptor-mediated calcium movements in Jurkat T-cells is due to increased calcium extrusion. J. Biol. Chem. 268:1993;20812-20817.
24. Pelassy C., Breittmayer J. P., Mary D., Aussel C. Inhibition of phosphatidylserine synthesis by phosphatidic acid in the Jurkat T cell line: Role of calcium ions released from intracellular stores. J. Lipid Mediat. 4:1991;99-209.
25. Graber M., Bockenstedt L. K., Weiss A. Signaling via the inositol phospholipid pathway by T cell antigen receptor is limited by receptor number. J. Immunol. 146:1991;2935-2943.
26. Rossetti R. G., Seiler C. M., Laposata M., Zurier R. B. Differential regulation of human T lymphocyte protein kinase C activity by unsaturated fatty acids. Clin. Immunol. Immunopathol. 76:1995;220-224.
27. Weiss A. T cell antigen receptor signal transduction: A tale of tails and cytoplasmic protein-tyrosine kinases. Cell. 73:1993;209-212.
28. DeLuca P., Rothman D., Zurier R. B. Marine and botanical lipids as immunomodulatory and therapeutic agents in the treatment of rheumatoid arthritis. Rheum. Dis. Clin. North Am. 21:1995;759-778.
29. Engelhard V. H., Glaser M., Storm D. R. Effect of membrane phospholipid compositional changes on adenylate cyclase in LM cells. Biochemistry. 17:1978;3191-3200.